the new anti-arrhythmic agent flecainide was compared in a single-blind cross-over study to arabogalactane quinidine sulfate in the treatment of stable chronic extrasystole , using a fixed twice-daily dose protocol .
C0003195
anti-arrhythmic agent
C0016229
flecainide